158 related articles for article (PubMed ID: 2473798)
1. Phenotypic heterogeneity of TDT+ cells in the blood and bone marrow: implications for surveillance of residual leukemia.
Smith RG; Kitchens RL
Blood; 1989 Jul; 74(1):312-9. PubMed ID: 2473798
[TBL] [Abstract][Full Text] [Related]
2. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
Hurwitz CA; Gore SD; Stone KD; Civin CI
Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
[TBL] [Abstract][Full Text] [Related]
4. Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells.
Gore SD; Kastan MB; Civin CI
Blood; 1991 Apr; 77(8):1681-90. PubMed ID: 2015396
[TBL] [Abstract][Full Text] [Related]
5. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7.
Grümayer ER; Griesinger F; Hummell DS; Brunning RD; Kersey JH
Blood; 1991 Jan; 77(1):64-8. PubMed ID: 1702030
[TBL] [Abstract][Full Text] [Related]
8. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors.
Farahat N; Lens D; Zomas A; Morilla R; Matutes E; Catovsky D
Br J Haematol; 1995 Nov; 91(3):640-6. PubMed ID: 8555067
[TBL] [Abstract][Full Text] [Related]
9. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
10. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
[TBL] [Abstract][Full Text] [Related]
11. Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
Gore SD; Kastan MB; Goodman SN; Civin CI
J Immunol Methods; 1990 Sep; 132(2):275-86. PubMed ID: 1698878
[TBL] [Abstract][Full Text] [Related]
12. Regeneration of CALLA (CD10+), TdT+ and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation.
Smedmyr B; Bengtsson M; Jakobsson A; Simonsson B; Oberg G; Tötterman TH
Eur J Haematol; 1991 Mar; 46(3):146-51. PubMed ID: 1826271
[TBL] [Abstract][Full Text] [Related]
13. Multiparameter flow cytometric analysis of human fetal bone marrow B cells.
LeBien TW; Wörmann B; Villablanca JG; Law CL; Steinberg LM; Shah VO; Loken MR
Leukemia; 1990 May; 4(5):354-8. PubMed ID: 1697009
[TBL] [Abstract][Full Text] [Related]
14. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny.
Dworzak MN; Fritsch G; Fröschl G; Printz D; Gadner H
Blood; 1998 Nov; 92(9):3203-9. PubMed ID: 9787156
[TBL] [Abstract][Full Text] [Related]
15. Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies.
Imamura N; Kuramoto A
Am J Hematol; 1991 Dec; 38(4):332-4. PubMed ID: 1836104
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
17. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
18. Immunobiologic differences between normal and leukemic human B-cell precursors.
Uckun FM; Ledbetter JA
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8603-7. PubMed ID: 2460871
[TBL] [Abstract][Full Text] [Related]
19. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD34 on human B cell precursors.
Schmitt C; Eaves CJ; Lansdorp PM
Clin Exp Immunol; 1991 Jul; 85(1):168-73. PubMed ID: 1712682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
